Pharmaceutical composition
US11311502B2 · kind B2 · utility
4Cited by
16References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2020 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | May 26, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one salmeterol compound selected from salmeterol and the pharmaceutically acceptable derivatives thereof; and (ii) a propellant component comprising 1,1-difluoroethane (HFA-152a).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.